期刊文献+

影响肺动脉高压患者预后的相关因素分析

Analysis for prognosis-related factors of pulmonary arterial hypertension
原文传递
导出
摘要 肺动脉高压是一种以肺血管阻力进行性增加为特征的潜在的致命性疾病,进展快,预后羞,多数患者在确诊后数年甚至数月内死亡,其预后与病因、人口统计学特征、血管反应性、病情严重程度、治疗等多种因素相关。 Pulmonary arterial hypertension is a latent fatal disease charactered by persistent increase of pulmonary vascular resistence. Its progress is rapid and prognosis bad. Most patients would die in several years or several months after being confirmed the diagnosis. The prognosis of pulmonary arterial hypertension is affected by some factors such as etiopathogenisis, demography, haemodynamics, severity of patient's condition and therapy.
出处 《国际呼吸杂志》 2009年第6期331-334,共4页 International Journal of Respiration
基金 国家十一五科技支撑计划基金(2006BA101A06)
关键词 肺动脉高压 运动耐量 治疗 预后 Pulmonary arterial hypertension Exercise tolerance Therapy Prognosis
  • 相关文献

参考文献18

  • 1D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension, Results from a national prospective registry. Ann Intern Med. 1991,115 : 343- 349.
  • 2Jing ZC, Xu XQ, Han ZY, et al, Registry and survival study in Chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest, 2007, 132:373 -379.
  • 3McLaughlin VV,Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence based clinical practice guidelines. Chest, 2004,126 ( 1 Suppl) : 78S- 92S.
  • 4Humbert M, Sitbon O,Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med, 2006,173 : 1023-1030.
  • 5Yung D, Widlitz. AC, Rosenzweig EB, et al. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation, 2004,1:10 : 660-665.
  • 6Kuhn KP, Byrne DW, Arbogast PG, et al. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med, 2003, L67:580-586.
  • 7Kawut SM,Horn EM,Berekashvili KK,et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol, 2005,95 : 199-203.
  • 8Elliott CG, Glissmeyer EW, Havlena GT, et al. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. Circulation, 2006,113 : 2509-2515.
  • 9Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation, 2005,111 :3105-3111.
  • 10Mahapatra S, Nishimura RA, Sorajja P, et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic puhnonary arterial hypertension. J Am Coll Cardiol,2006,47: 799-803.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部